Daiichi Sankyo is running rolling applications for sponsored research/research collaboration opportunities for drug discovery programs in:
- Oncology
- Immune disease
- Neurodegenerative disease (AD, Parkinson’s, ALS)
- Psychiatric disease (Schizophrenia, ASD, Addition/Anxiety, Depression)
- Rare Diseases of CNS and Liver
- Ophthalmology disorders (AMD, RP, and PDR)
Further, they are interested in:
- siRNA drug delivery techs to brain, heart, lung, and kidney
- AAV platform techs (new capsids for CNS targets)
- RNA-targeting small molecules or editing techs
- In vivo or vitro models that recapitulate immune and CNS disorders
Complete details for their areas-of-interest can be found here.
Deadline: no immediate deadline, rolling application until March 2024
Budget: up to $230K / year for 1-3 years
Term: 1-3 years after which projects can be staged for continued collaboration
Details here.